Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-788-0 | CAS number: 87-99-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Mutagenic effects - bacterial: Ames study, OECD 471; Negative. Reliability = 2.
Clastogenic effects - mammalian: In vitro chromosome aberration test in human lymphocytes, OECD 473; Negative. OECD 473; Reliability = 2.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- 3 strains of bacterial used
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- histidine
- Species / strain / cell type:
- S. typhimurium TA 1535
- Species / strain / cell type:
- S. typhimurium TA 1537
- Species / strain / cell type:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Metabolic activation system:
- S-9
- Test concentrations with justification for top dose:
- 0, 15.6, 31.25, 62.5 and 125 mg/plate
- Vehicle / solvent:
- dissolved in phosphate buffered saline
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- not specified
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- 3-methylcholanthrene
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS: 4
- Statistics:
- The statistical analysis according to KAPLAN has previously been described.
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- Only in the first experiment, with the highest dose of the compound added to the bacteria and only after metabolic activation a significant (p< 0.01), about twofold increase of the revertants above background could be observed with Salmonella typhimurium TA 1538. As usually in the AMES test only three times more revertant colonies as compared to the background are considered to be a positive result and as this observation could not be reproduced, the authors do not think this finding to be of great relevance. Moreover, even in an experiment with 10 plates per dosage group the result could not be reproduced, while with the positive control 3-MCA a 15-fold increase of the revertant colonies above background could be observed.
- Conclusions:
- Ames test is negative.
- Executive summary:
The Ames test with Salmonella typhimurium TA 1535, TA 1537 and TA 1538 was carried out to assess the potential mutagenic activity of the test substance. Only in the first experiment, with the highest dose of the compound added to the bacteria and only after metabolic activation a significant (p< 0.01), about twofold increase of the revertants above background could be observed with Salmonella typhimurium TA 1538. Although this increase is statistically significant, it is very likely to be an artefact due to the biological variation of the system, as the effect could not be reproduced in further experiments and as usually only a threefold increase of revertant colonies above background or more is considered to be positive. Neither the test substance nor one of its metabolites formed by a rat liver microsomal fraction was able to induce gene mutations.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- host-mediated assay
- GLP compliance:
- not specified
- Type of assay:
- bacterial forward mutation assay
- Target gene:
- histidine
- Species / strain / cell type:
- S. typhimurium, other: TA 1530
- Species / strain / cell type:
- S. typhimurium, other: TA 1532
- Species / strain / cell type:
- S. typhimurium, other: TA 1964
- Metabolic activation:
- with
- Metabolic activation system:
- host-mediated assay; Füllinsdorf Albino mice
- Test concentrations with justification for top dose:
- 0, 1820, 3280 and 5333 mg/kg/body weight of mice
- Vehicle / solvent:
- distilled water
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- not specified
- True negative controls:
- not specified
- Positive controls:
- not specified
- Details on test system and experimental conditions:
- As hosts Füllinsdorf Albino mice (SPF, 4 male and 4 female per dosage group, average weight about 30 g) and as indicator organisms various Salmonella typhimurium strains (TA 1530 = BPS, TA 1532 = FS, TA 1964 = FS), also were used. The test substance was dissolved in distilled water and applicated once per os together with the bacteria which were given intraperitoneally three hours prior to the sacrifice of the mice.
- Statistics:
- The statistical analysis was performed by means of the Student-t-test.
- Species / strain:
- S. typhimurium, other: TA 1530
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Species / strain:
- S. typhimurium, other: TA 1532
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Species / strain:
- S. typhimurium, other: TA 1964
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Conclusions:
- The test substance caused no observable mutagenic effect in the system studied.
- Executive summary:
The host-mediated assay in the mouse with Salmonella typhimurium was carried out to assess potential mutagenic activity of the test substance. As hosts Füllinsdorf Albino mice (SPF, 4 male and 4 female per dosage group) and as indicator organisms various Salmonella typhimurium strains (TA 1530, TA 1532 TA 1964), also were used.
No significant increase of the number of revertant colonies above background could be shown in the experiments. Thus, neither the test substance nor one of its metabolites, which may have been formed in the mouse are mutagenic for the Salmonella typhimurium strains used.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- no positive control or metabolic activation
- GLP compliance:
- not specified
- Type of assay:
- mammalian cell gene mutation assay
- Species / strain / cell type:
- lymphocytes: PHA-stimulated human
- Metabolic activation:
- not specified
- Test concentrations with justification for top dose:
- first experiment: 0, 0.45, 0.85, 1.75, 3.5 and 7 mg/mL
second experiment: 0, 3.5, 7 and 14 mg/mL - Vehicle / solvent:
- Hanks Balanced Salt Solution
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- no
- Details on test system and experimental conditions:
- 0.25 mL peripheral blood of a 29-year old woman, respectively a 22-year old man in the second experiment, were cultured in 5 mL medium consisting of TC-199 medium supplemented with 25% foetal calf serum, 0.25% liquemine and 1% phytohemagglutinin (PHA, Wellcome), a mitogen for T-lymphocytes. The blood was incubated in plastic tissue culture flasks in a humidified incubator at 37ºC with 5% CO2 in air for three days.
The test substance was dissolved in Hanks Balanced Salt Solution and added to the cultures 24 hours prior to the harvest of the cells. - Evaluation criteria:
- Only the cultures with the highest doses and the control cultures of each experiment were evaluated. 100 cells per dosage group and 50 cells for the control group for each experiment were checked for chromosome or chromatid aberrations.
- Statistics:
- The statistical analysis of the results was performed according to the method of Ustenmum and Bowman.
- Species / strain:
- lymphocytes: PHA-stimulated human
- Metabolic activation:
- not specified
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Additional information on results:
- No increase of aberration rate in lymphocyte cultures treated with doses of the test substance up to 14 mg/mL as compared to the untreated cultures was shown.
- Conclusions:
- The test substance caused no observable mutagenic effects in the system studied.
- Executive summary:
A cultivated human lymphocyte test was carried out to assess the potential mutagenicity of the test substance. Blood was collected from a young male and female human and the lymphocytes incubated for 3 days. The test substance, at concentrations up to 14 mg/mL, was dissolved in Hanks Balanced Salt Solution and added to the cultures 24 hours prior to the harvest of the cells. The test substance did not cause any chromosome or chromatid aberrations in cultivated human lymphocytes. No increase of the aberration rate in treated lymphocyte cultures was seen as compared to the untreated cultures.
Referenceopen allclose all
No significant increase of the number of revertant colonies above background could be shown in the experiments. Thus, neither the test substance nor one of its metabolites, which may have been formed in the mouse are mutagenic for the Salmonella typhimurium strains used.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Clastogenic effects - mammalian: In vivo mouse micronucleus, equivalent to OECD 474. Negative. Reliability = 2
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- no positive controls
- GLP compliance:
- not specified
- Type of assay:
- micronucleus assay
- Species:
- mouse
- Strain:
- other: Fullinsdorf albino (SPF)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Males: average weight about 38 g
Females: average weight about 33 g - Route of administration:
- oral: gavage
- Vehicle:
- dissolved in PBS
- Duration of treatment / exposure:
- treated twice, 30 and 6 hours before sacrifice
- Frequency of treatment:
- two times
- Dose / conc.:
- 1 820 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 3 280 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 5 333 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 3/sex/dose
- Control animals:
- yes
- Positive control(s):
- no data
- Tissues and cell types examined:
- Smears of the bone marrow of both femora were prepared and stained as described by Schuepbach. 4000 erythrocytes per animal were checked for micronuclei.
- Details of tissue and slide preparation:
- Bone marrow was collected in foetal calf serum from the femur of each animal. The tube was centrifuged at 1000 rev/min for 5 minutes. The supernatant is removed and the cells in the sediment were carefully mixed by aspiration using a pipette. A small drop of the suspension was smeared on a fresh microscope slide, and the slides were air dried. Slides were stained with May-Gruenwald solution, May-Gruenwald diluted with distilled water (1:1), followed by Giemsa diluted with distilled water (1:6). Slides were then rinsed in distilled water, blotted dry and the back was cleaned with methanol. The slide was cleared in xylene and a cover glass was mounted.
- Statistics:
- The statistical analysis was performed by means of the Student-t-test.
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- not specified
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Additional information on results:
- After two-fold application of the test substance (doses up to 5333 mg/kg) no significant increase of micronuclei containing erythrocytes could be shown in the bone marrow of Füllinsdorf Albino mice of either sex.
- Conclusions:
- The test substance caused no observable mutagenic effect in the system studied.
- Executive summary:
The micronucleus test in the mouse was carried out to assess potential mutagenic activity of the test substance. Three male and three female mice were used per dosage group. They were treated twice, 30 and 6 hours before sacrifice, with up to 5333 mg/kg of the test substance dissolved in PBS. Erythrocytes were checked for micronuclei. After twofold applications, no significant increase of micronuclei containing erythrocytes could be shown in the bone marrow of Füllinsdorf Albino mice of either sex. Therefore, the test substance causes neither chromosome breaks nor mitotic non-disjunction in the bone marrow of the mouse.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Xylitol caused no observable mutagenic effects in any of the systems studied. The analysis included an Ames test with Salmonella typhimurium TA 1535, TA 1537, and TA 1538 with and without S-9 metabolic activation; host-mediated assay in the mouse with Salmonella typhimurium TA 1530, TA 1532, and TA 1964; micronucleus test with Fullinsdorf albino mice; and chromosome analysis of cultured, PHA-stimulated human lymphocytes. Each of these in vivo and in vitro tests for mutagenicity and clastogenicity have consistently yielded negative results.
Justification for classification or non-classification
The test substance did not produce mutagenicity in vitro or clastogenicity when evaluated in vitro and in laboratory animals. Based on an assessment of the robust genetic toxicity data for this substance, the substance does not need to be classified for germ-cell mutagenicity according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.